Search Results - "Lebron, Belinda Rivera"

Refine Results
  1. 1

    Pulmonary embolism response teams: Changing the paradigm in the care for acute pulmonary embolism by Porres‐Aguilar, Mateo, Rosovsky, Rachel P., RiveraLebron, Belinda N., Kaatz, Scott, Mukherjee, Debabrata, Anaya‐Ayala, Javier E., Jimenez, David, Jerjes‐Sánchez, Carlos

    Published in Journal of thrombosis and haemostasis (01-11-2022)
    “…Pulmonary embolism response teams (PERTs) have emerged as a multidisciplinary, multispecialty team of experts in the care of highly complex symptomatic acute…”
    Get full text
    Journal Article
  2. 2

    Invasive hemodynamic assessment of patients with submassive pulmonary embolism by Khandhar, Sameer J., Mehta, Mili, Cilia, Lindsey, Palevsky, Harold, Matthai, William, RiveraLebron, Belinda, Toma, Catalin

    “…Objectives To investigate the invasive hemodynamics in patients with intermediate‐risk pulmonary embolism (PE) and the change that occurs with…”
    Get full text
    Journal Article
  3. 3

    Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions by Rosovsky, Rachel, Zhao, Ken, Sista, Akhilesh, RiveraLebron, Belinda, Kabrhel, Christopher

    “…Pulmonary embolism (PE) is a major cause of morbidity and mortality in the United States. Although new therapeutic tools and strategies have recently been…”
    Get full text
    Journal Article
  4. 4

    Echocardiographic and Hemodynamic Predictors of Mortality in Idiopathic Pulmonary Fibrosis by Rivera-Lebron, Belinda N., MD, Forfia, Paul R., MD, FCCP, Kreider, Maryl, MD, Lee, James C., MD, Holmes, John H., PhD, Kawut, Steven M., MD, FCCP

    Published in Chest (01-08-2013)
    “…Background Idiopathic pulmonary fibrosis (IPF) can lead to the development of pulmonary hypertension, which is associated with an increased risk of death. In…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Outcomes of catheter-directed thrombolysis vs. standard medical therapy in patients with acute submassive pulmonary embolism by D’Auria, Stephen, Sezer, Ahmet, Thoma, Floyd, Sharbaugh, Michael, McKibben, Jeffrey, Maholic, Robert, Avgerinos, Efthymios D., Rivera-Lebron, Belinda N., Toma, Catalin

    Published in Pulmonary circulation (01-01-2020)
    “…Background Catheter-directed thrombolysis (CDL) is increasingly being used for the treatment of submassive and massive pulmonary embolism. Although this…”
    Get full text
    Journal Article
  7. 7

    Ambrisentan: a review of its use in pulmonary arterial hypertension by Rivera-Lebron, Belinda N., Risbano, Michael G.

    “…Pulmonary arterial hypertension (PAH) is a progressive disease defined by an elevation in pulmonary arterial pressure that can lead to right heart failure and…”
    Get full text
    Book Review Journal Article
  8. 8

    The PERT Concept: A Step-by-Step Approach to Managing Pulmonary Embolism by Rivera-Lebron, Belinda N, Rali, Parth M, Tapson, Victor F

    Published in Chest (01-01-2021)
    “…Pulmonary embolism (PE) is a major source of morbidity and mortality. The presentation of acute PE varies, ranging from few or no symptoms to sudden death…”
    Get full text
    Journal Article
  9. 9

    Clinical outcomes of inferior vena cava filter in complicated pulmonary embolism by Gul, Muhammad H., Htun, Zin M., Rigdon, Joseph, Rivera-Lebron, Belinda, Perez, Vinicio de Jesus

    Published in Pulmonary circulation (01-10-2019)
    “…Background: Previous observational studies suggest that inferior vena cava filter placement in pulmonary embolism patients complicated with congestive heart…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Randomized Trial Comparing Standard Versus Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism: The SUNSET sPE Trial by Avgerinos, Efthymios D, Jaber, Wissam, Lacomis, Joan, Markel, Kyle, McDaniel, Michael, Rivera-Lebron, Belinda N, Ross, Charles B, Sechrist, Jacob, Toma, Catalin, Chaer, Rabih

    Published in JACC. Cardiovascular interventions (28-06-2021)
    “…The aim of this trial was to determine whether ultrasound-assisted thrombolysis (USAT) is superior to standard catheter-directed thrombolysis (SCDT) in…”
    Get full text
    Journal Article
  12. 12

    Determinants of 6-Minute Walk Distance in Patients with Idiopathic Pulmonary Fibrosis Undergoing Lung Transplant Evaluation by Porteous, Mary K., Rivera-Lebron, Belinda N., Kreider, Maryl, Lee, James, Kawut, Steven M.

    Published in Pulmonary circulation (01-03-2016)
    “…Little is known about the physiologic determinants of 6-minute walk distance in idiopathic pulmonary fibrosis. We investigated the demographic, pulmonary…”
    Get full text
    Journal Article
  13. 13

    Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertension by Coons, James C., Bunner, Cheryl, Ishizawar, David C., Risbano, Michael G., Rivera-Lebron, Belinda, Mathier, Michael A., Chan, Stephen Y., Simon, Marc A.

    Published in Pulmonary circulation (01-01-2018)
    “…Oral treprostinil (TRE) is a prostacylin that is approved for the treatment of patients with pulmonary arterial hypertension (PAH). Dosing is approved for two…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Outcomes of Pulmonary Arterial Hypertension Are Improved in a Specialty Care Center by Pi, Hongyang, Kosanovich, Chad M., Handen, Adam, Tao, Michael, Visina, Jacqueline, Vanspeybroeck, Gabrielle, Simon, Marc A., Risbano, Michael G., Desai, Aken, Mathier, Michael A., Rivera-Lebron, Belinda N., Nguyen, Quyen, Kliner, Jennifer, Nouraie, Mehdi, Chan, Stephen Y.

    Published in Chest (01-07-2020)
    “…Pulmonary arterial hypertension (PAH) is characterized by elevated pulmonary arterial pressures and is managed by vasodilator therapies. Current guidelines…”
    Get full text
    Journal Article
  16. 16

    A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism by Avgerinos, Efthymios D., Saadeddin, Zein, Abou Ali, Adham N., Fish, Larry, Toma, Catalin, Chaer, Maria, Rivera-Lebron, Belinda N., Chaer, Rabih A.

    “…During the past few years, there has been a surge in the use of catheter-directed thrombolysis (CDT) for acute pulmonary embolism (PE), in the form of either…”
    Get full text
    Journal Article
  17. 17

    Venous Thromboembolism in Special Populations: Preexisting Cardiopulmonary Disease, Cirrhosis, End-Stage Renal Disease, and Asplenia by Nguyen, Quyen, Rivera-Lebron, Belinda N

    Published in Clinics in chest medicine (01-09-2018)
    “…Venous thromboembolism (VTE) is a common cause of morbidity and mortality. Presence of preexisting conditions, such as cardiopulmonary diseases, cirrhosis,…”
    Get full text
    Journal Article
  18. 18

    Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension by Porres-Aguilar, Mateo, Hoeper, Marius M., Rivera-Lebron, Belinda N., Heresi, Gustavo A., Mukherjee, Debabrata, Tapson, Victor F.

    Published in Journal of thrombosis and thrombolysis (01-10-2021)
    “…Chronic thromboembolic pulmonary hypertension (CTEPH) represents the later stage consequence of at least one or more unresolved episodes of acute pulmonary…”
    Get full text
    Journal Article
  19. 19

    Clinical outcomes and factors associated with pulmonary infarction following acute pulmonary embolism: a retrospective observational study at a US academic centre by Lio, Ka U, O'Corragain, Oisin, Bashir, Riyaz, Brosnahan, Shari, Cohen, Gary, Lakhter, Vladimir, Panaro, Joseph, Rivera-Lebron, Belinda, Rali, Parth

    Published in BMJ open (29-12-2022)
    “…Pulmonary infarction is a common clinical and radiographic finding in acute pulmonary embolism (PE), yet the clinical relevance and prognostic significance of…”
    Get full text
    Journal Article
  20. 20

    Pulmonary Embolism Response Teams: A Novel Approach for the Care of Complex Patients With Pulmonary Embolism by Porres–Aguilar, Mateo, Anaya-Ayala, Javier E., Heresi, Gustavo A., Rivera-Lebron, Belinda N.

    Published in Clinical and Applied Thrombosis/Hemostasis (01-12-2018)
    “…Pulmonary embolism represents the third most common cause of cardiovascular death in the United States. Reperfusion therapeutic strategies such as systemic…”
    Get full text
    Book Review Journal Article